(2S;3R;4S)-4-Hydroxyisoleucine
Product Sizes
25 mg
£ POA
HY-W010271-25MG
100 mg
£ POA
HY-W010271-100MG
50 mg
£ POA
HY-W010271-50MG
500 mg
£ POA
HY-W010271-500MG
1 g
£ POA
HY-W010271-1G
5 g
£ POA
HY-W010271-5G
10mM/1mL
£ POA
HY-W010271-10MM
About this Product
- SKU:
- HY-W010271
- Additional Names:
- (2S;3R;4S)-4-Hydroxy-L-isoleucine
- Application:
- Electron Microscopy
- CAS Number:
- 55399-93-4
- Extra Details:
- (2S;3R;4S)-4-Hydroxyisoleucine is an orally active compound. (2S;3R;4S)-4-Hydroxyisoleucine can be isolated from Trigonella foenum-graecum. (2S;3R;4S)-4-Hydroxyisoleucine has anti-diabetic and anti-diabetic nephropathy activity[1][2][3].
- Molecular Weight:
- 147.17
- Purity:
- 98.0
- References:
- [1]Shi X, et al. Engineering a short-chain dehydrogenase/reductase for the stereoselective production of (2S,3R,4S)-4-hydroxyisoleucine with three asymmetric centers. Sci Rep. 2017 Oct 20;7(1):13703.|[2]Broca C, et al. 4-Hydroxyisoleucine: effects of synthetic and natural analogues on insulin secretion. Eur J Pharmacol. 2000 Mar 3;390(3):339-45.|[3]Haeri MR, et al. Non-insulin dependent anti-diabetic activity of (2S, 3R, 4S) 4-hydroxyisoleucine of fenugreek (Trigonella foenum graecum) in streptozotocin-induced type I diabetic rats. Phytomedicine. 2012 May 15;19(7):571-4.
- Research Area:
- Metabolic Disease
- Shipping Conditions:
- Ambient
- Storage Conditions:
- -20[o]C; 3 years; 4[o]C; 2 years (Powder)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Small Molecules
- Pathway:
- Protein Tyrosine Kinase/RTK
